tiprankstipranks
Advertisement

ILOW - ETF AI Analysis

Compare

Top Page

ILOW

AB International Low Volatility Equity ETF (ILOW)

Rating:61Neutral
Price Target:
ILOW, the AB International Low Volatility Equity ETF, has a solid overall rating driven mainly by high-quality healthcare leaders like AstraZeneca and Novartis, which benefit from strong financial performance, positive earnings calls, and promising product pipelines. ASML and Roche also add strength through robust revenue growth and strategic initiatives, though their relatively high valuations and some overbought or bearish technical signals, along with similar concerns for other holdings, keep the fund’s rating from being higher and highlight valuation and technical risk as key factors to watch.
Positive Factors
Strong Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Leading Holdings Performing Well
Several of the largest positions, including Schneider Electric, BAE Systems, ASML, and Prysmian, have delivered strong year-to-date results that support the fund’s overall performance.
Broad Global and Sector Diversification
Holdings spread across many countries and industries help reduce the impact if any single market or sector runs into trouble.
Negative Factors
Moderately High Expense Ratio
The fund’s fee level is on the higher side for an ETF, which can slightly reduce long-term returns compared with lower-cost options.
Heavy Tilt Toward Europe and the UK
A large share of assets is concentrated in European and UK markets, which increases sensitivity to economic or political issues in those regions.
Limited Exposure to High-Growth Tech
Technology makes up only a small portion of the portfolio, so the fund may lag more tech-heavy funds during strong technology market rallies.

ILOW vs. SPDR S&P 500 ETF (SPY)

ILOW Summary

AB International Low Volatility Equity ETF (ILOW) is an actively managed fund that invests in stocks from many countries outside the U.S., aiming to pick companies whose share prices have been relatively steady over time. It doesn’t track a specific index, but follows a “low volatility” theme across a broad mix of sectors and regions like the UK, Japan, and Europe. Well-known holdings include AstraZeneca and ASML. Investors might consider it for global diversification with a focus on smoother returns. A key risk is that it still owns stocks, so its value can rise or fall with global markets.
How much will it cost me?The AB International Low Volatility Equity ETF (ILOW) has an expense ratio of 0.5%, meaning you’ll pay $5 per year for every $1,000 invested. This is higher than average for ETFs because it uses an actively managed strategy to select stocks with lower volatility, which requires more research and management compared to passively managed funds. It’s designed for investors seeking stability in international markets.
What would affect this ETF?The AB International Low Volatility Equity ETF (ILOW) could benefit from global economic stability and growth, particularly in sectors like financials, technology, and healthcare, which make up a significant portion of its holdings. However, it may face challenges from rising interest rates, geopolitical tensions, or regulatory changes in the international markets where it operates, potentially impacting its broad-based exposure and top holdings like SAP SE and Shell. Its focus on low-volatility stocks may help mitigate risks during market downturns but could limit returns in high-growth periods.

ILOW Top 10 Holdings

ILOW’s story is about steady, low-drama growth powered by a global mix of defensive and industrial names outside the U.S. Schneider Electric and ASML are doing much of the heavy lifting, with both stocks rising and giving the fund a quiet boost from Europe’s industrial and semiconductor backbone. Prysmian has been another bright spot, sprinting ahead and adding momentum. On the steadier side, AstraZeneca and Novartis are humming along, while BAE Systems and OCBC are more mixed, occasionally losing steam and slightly dampening an otherwise resilient, broadly diversified ex-U.S. lineup.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Schneider Electric2.24%$38.62M€155.45B27.66%
62
Neutral
ASML Holding NV2.00%$34.42M€477.33B106.32%
76
Outperform
Prysmian SpA1.97%$34.03M€36.54B158.94%
65
Neutral
AstraZeneca1.93%$33.32M$292.69B32.74%
80
Outperform
Euronext NV1.92%$33.15M€14.52B1.73%
65
Neutral
BAE Systems1.91%$32.95M£59.22B23.73%
61
Neutral
Tesco plc1.85%$31.88M£31.16B34.38%
74
Outperform
Enel S.p.A.1.78%$30.69M€99.75B29.89%
67
Neutral
Roche Holding AG1.76%$30.29M$327.04B22.13%
73
Outperform
OCBC1.75%$30.21MS$97.57B29.04%
71
Outperform

ILOW Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
43.81
Positive
100DMA
43.60
Positive
200DMA
42.50
Positive
Market Momentum
MACD
0.24
Positive
RSI
53.86
Neutral
STOCH
43.59
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ILOW, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 44.53, equal to the 50-day MA of 43.81, and equal to the 200-day MA of 42.50, indicating a bullish trend. The MACD of 0.24 indicates Positive momentum. The RSI at 53.86 is Neutral, neither overbought nor oversold. The STOCH value of 43.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ILOW.

ILOW Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.73B0.50%
61
Neutral
$1.66B0.54%
62
Neutral
$1.30B0.85%
62
Neutral
$1.14B0.65%
67
Neutral
$1.00B0.45%
64
Neutral
$994.63M0.59%
67
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ILOW
AB International Low Volatility Equity ETF
44.56
5.45
13.94%
CGIC
Capital Group International Core Equity ETF
WCMI
First Trust WCM International Equity ETF
IDVO
Amplify International Enhanced Dividend Income ETF
APIE
ActivePassive International Equity ETF
MFSI
MFS Active International ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement